Northern Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$394K Sell
416,372
-693,515
-62% -$656K ﹤0.01% 3727
2025
Q1
$511K Sell
1,109,887
-198,764
-15% -$91.6K ﹤0.01% 3573
2024
Q4
$966K Buy
1,308,651
+164,620
+14% +$122K ﹤0.01% 3410
2024
Q3
$1.8M Buy
1,144,031
+146,503
+15% +$230K ﹤0.01% 3066
2024
Q2
$1.68M Buy
997,528
+130,972
+15% +$220K ﹤0.01% 2995
2024
Q1
$2.08M Buy
866,556
+6,968
+0.8% +$16.7K ﹤0.01% 2937
2023
Q4
$1.32M Sell
859,588
-291,229
-25% -$446K ﹤0.01% 3209
2023
Q3
$1.25M Buy
1,150,817
+68,986
+6% +$75.2K ﹤0.01% 3194
2023
Q2
$2.48M Buy
1,081,831
+318,567
+42% +$730K ﹤0.01% 2889
2023
Q1
$1.85M Sell
763,264
-23,707
-3% -$57.6K ﹤0.01% 2973
2022
Q4
$1.5M Buy
786,971
+51,461
+7% +$98.3K ﹤0.01% 3125
2022
Q3
$1.77M Buy
735,510
+63,047
+9% +$151K ﹤0.01% 3083
2022
Q2
$1.25M Buy
672,463
+12,057
+2% +$22.4K ﹤0.01% 3281
2022
Q1
$1.38M Sell
660,406
-27,970
-4% -$58.4K ﹤0.01% 3275
2021
Q4
$2.71M Buy
688,376
+298
+0% +$1.17K ﹤0.01% 3067
2021
Q3
$3.31M Sell
688,078
-39,918
-5% -$192K ﹤0.01% 3004
2021
Q2
$3.34M Buy
727,996
+131,765
+22% +$605K ﹤0.01% 3083
2021
Q1
$3.5M Buy
596,231
+56,436
+10% +$331K ﹤0.01% 2960
2020
Q4
$1.85M Buy
539,795
+850
+0.2% +$2.91K ﹤0.01% 3228
2020
Q3
$776K Sell
538,945
-20,206
-4% -$29.1K ﹤0.01% 3492
2020
Q2
$1.12M Sell
559,151
-22,398
-4% -$44.7K ﹤0.01% 3315
2020
Q1
$1.13M Buy
581,549
+48,006
+9% +$93.6K ﹤0.01% 3153
2019
Q4
$2.21M Buy
533,543
+9,102
+2% +$37.8K ﹤0.01% 3072
2019
Q3
$1.58M Sell
524,441
-31,089
-6% -$93.5K ﹤0.01% 3227
2019
Q2
$3.49M Sell
555,530
-38,302
-6% -$241K ﹤0.01% 2751
2019
Q1
$3.3M Sell
593,832
-11,932
-2% -$66.3K ﹤0.01% 2796
2018
Q4
$4.02M Sell
605,764
-12,479
-2% -$82.9K ﹤0.01% 2639
2018
Q3
$6.6M Buy
618,243
+33,850
+6% +$361K ﹤0.01% 2525
2018
Q2
$7.01M Buy
584,393
+12,289
+2% +$147K ﹤0.01% 2491
2018
Q1
$4.9M Sell
572,104
-20,205
-3% -$173K ﹤0.01% 2607
2017
Q4
$5.85M Sell
592,309
-7,581
-1% -$74.9K ﹤0.01% 2513
2017
Q3
$7.37M Sell
599,890
-14,643
-2% -$180K ﹤0.01% 2385
2017
Q2
$10.1M Buy
614,533
+19,525
+3% +$321K ﹤0.01% 2178
2017
Q1
$8.53M Buy
595,008
+10,040
+2% +$144K ﹤0.01% 2222
2016
Q4
$8.09M Buy
584,968
+19,650
+3% +$272K ﹤0.01% 2244
2016
Q3
$10.2M Buy
565,318
+29,530
+6% +$534K ﹤0.01% 2062
2016
Q2
$7.69M Buy
535,788
+51,842
+11% +$744K ﹤0.01% 2193
2016
Q1
$5.78M Buy
483,946
+9,030
+2% +$108K ﹤0.01% 2321
2015
Q4
$6.32M Buy
474,916
+12,389
+3% +$165K ﹤0.01% 2320
2015
Q3
$4.97M Buy
462,527
+63,269
+16% +$680K ﹤0.01% 2452
2015
Q2
$3.21M Buy
399,258
+14,217
+4% +$114K ﹤0.01% 2799
2015
Q1
$2.55M Buy
385,041
+1,048
+0.3% +$6.93K ﹤0.01% 2979
2014
Q4
$2.45M Buy
383,993
+16,738
+5% +$107K ﹤0.01% 2973
2014
Q3
$3.63M Sell
367,255
-9,724
-3% -$96K ﹤0.01% 2727
2014
Q2
$4.25M Sell
376,979
-45,922
-11% -$517K ﹤0.01% 2626
2014
Q1
$5.12M Sell
422,901
-43,333
-9% -$525K ﹤0.01% 2535
2013
Q4
$5.87M Sell
466,234
-4,644
-1% -$58.5K ﹤0.01% 2444
2013
Q3
$7.85M Sell
470,878
-28,703
-6% -$478K ﹤0.01% 2185
2013
Q2
$7.59M Buy
+499,581
New +$7.59M ﹤0.01% 2128